Company / Current Assets per Share
Olema Pharmaceuticals, Inc. Current Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7.46
FY2024
5-year range
$5.22 / $48.73
FY2020-FY2024
Trend
+26.7%
vs FY2023
Sector context
#99 of 210
Health Care
What the data says
At $7.46, Olema Pharmaceuticals, Inc.'s current assets per share ranks #99 of 210 in the Health Care sector. Improved from $5.22 to $7.46 over the past 2 years.
Based on SEC 10-K filings.
7.46 in FY2024 with a 3-year CAGR of +0.5%.
Improved from $5.22 to $7.46 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +0.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#99 of 210 in Health CareTop 47% of 210This company $7.46 Sector average $170.65
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 26.7% year-over-year.
- Ranks #99 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.46 | +26.7% |
| FY2023 | $5.89 | +12.8% |
| FY2022 | $5.22 | -29.0% |
| FY2021 | $7.35 | -84.9% |
| FY2020 | $48.73 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026